Europe's healthcare digitalization is deeply transforming how women look after their bodies and minds. The Europe Women's Digital Health Market, including mobile health (mHealth) applications, wearable’s, telemedicine, digital therapeutics (DTx), and AI-analyzed analytics, is personalizing, accessible, and preventive healthcare at every stage of a woman's life.
Growing consciousness regarding reproductive health, fertility control, prevention of long-term diseases, and menopause management has made European women more independent and conscious of their health.
Post-pandemic acceleration of adoption of telemedicine has occurred, with public health policies and digital strategies of the European Union further supporting innovation in the FemTech ecosystem.
The industry is growing rapidly, with expected growth from USD 2.8 Billion in 2024 to USD 7.2 Billion by 2034, at a CAGR of nearly 9.8 percent.
Growth drivers are widespread adoption of digital health platforms and wearable’s, significant government push on telemedicine and digital access to healthcare, increased investment in FemTech, and growing interest in wellbeing with respect to reproductive, hormonal and mental health.
The industry has challenges around the burden of regulatory compliance with national health authorities and GDPR and people’s variances of digital health literacy and access across regions,
Major players in this market include Clue by BioWink GmbH, Natural Cycles, Flo Health Inc., Elvie, Livi (Kry International), Philips Healthcare, Fitbit (Google), HeraMED, FemTec Health, and Maven Clinic. The market is bifurcated into types, applications, and end user.
By types, the market is segmented as mobile health applications, wearables, telehealth, digital therapeutics, and AI-enabled health analytics.
Applications are segmented as menstruation, fertility tracking, pregnancy and postpartum care, menopause and hormonal balancing, mental health and wellbeing, and chronic disease and lifestyle management. End user segments are hospitals and clinics,
In conclusion, mobile apps and wearables are leading in the European market, which aligns with Europe's goal of self-monitoring and connected health.
Fertility tracking and period health apps have the largest share of the market, in part, because of greater awareness of reproductive issues and the development of AI-enabled cycle prediction.
Meanwhile, the rise in digital therapeutics and mental wellness apps continues to grow as women increasingly access.
We use cookies to ensure you get the best experience on our website. Read more...
Copyright © All rights reserved. Global Woman Leader